UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease

Journal of personalized medicine, 2022-02, Vol.12 (2), p.269

2022

Volltextzugriff (PDF)

Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart Disease

Diseases, 2023-10, Vol.11 (4), p.145

2023

Volltextzugriff (PDF)

Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries

Biomolecules (Basel, Switzerland), 2021-02, Vol.11 (2), p.257

2021

Volltextzugriff (PDF)

The Association of Lipoprotein(a) and Circulating Monocyte Subsets with Severe Coronary Atherosclerosis

Journal of cardiovascular development and disease, 2021-06, Vol.8 (6), p.63

2021

Volltextzugriff (PDF)

Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease

Journal of cardiovascular development and disease, 2021-01, Vol.8 (2), p.11

2021

Volltextzugriff (PDF)

Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction

Frontiers in cardiovascular medicine, 2022-03, Vol.9, p.843602-843602

2022

Volltextzugriff (PDF)

Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis

Diseases, 2022-01, Vol.10 (1), p.6

2022

Volltextzugriff (PDF)

Therapeutic Apheresis for Management of Lp(a) Hyperlipoproteinemia

Current atherosclerosis reports, 2020-09, Vol.22 (11), p.68-68, Article 68

2020

Volltextzugriff (PDF)

Lipoprotein(a) apheresis

Current opinion in lipidology, 2016-08, Vol.27 (4), p.351-358

2016

Volltextzugriff (PDF)

Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia

Atherosclerosis, 2018-10, Vol.277, p.477-482

2018

Volltextzugriff (PDF)

Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting

Atherosclerosis, 2014-08, Vol.235 (2), p.477-482

2014

Volltextzugriff (PDF)

Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography

Atherosclerosis. Supplements, 2013-01, Vol.14 (1), p.93-99

2013

Volltextzugriff (PDF)

Dramatic fate of a young coronary heart disease patient rescued with specific lipoprotein(a) apheresis

Journal of clinical apheresis, 2015-06, Vol.30 (3), p.193-195

2015

Volltextzugriff (PDF)

Abstract 13769: Assessing the Risk for Cardiovascular Diseases According to Lipoprotein(a) Levels

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A13769-A13769

2020

Volltextzugriff (PDF)

Block synthesis of blood group tetrasaccharides B (types 1, 3 and 4)

Mendeleev communications, 2009-05, Vol.19 (3), p.152-154

2009

Volltextzugriff (PDF)

Association of lipoprotein(a) excess with early vein graft occlusions in middle-aged men undergoing coronary artery bypass surgery

The Journal of thoracic and cardiovascular surgery, 2003-10, Vol.126 (4), p.1071-1075

2003

Volltextzugriff (PDF)

Lipoprotein Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart Disease

Diseases, 2023-10, Vol.11 (4)

2023

Volltextzugriff (PDF)

Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis

Atherosclerosis. Supplements, 2017-11, Vol.30, p.187-192

2017

Volltextzugriff (PDF)

Cascade plasma filtration during the first year after CABG in patients with hyperlipidemia refractory to statins

Atherosclerosis. Supplements, 2013-01, Vol.14 (1), p.101-105

2013

Volltextzugriff (PDF)

Extracorporeal immunoadsorption for the specific removal of lipoprotein (a) (Lp(a) apheresis): preliminary clinical data

Chemistry and physics of lipids, 1994, Vol.67, p.323-330

1994

Volltextzugriff (PDF)

Dramatic fate of a young coronary heart disease patient rescued with specific lipoprotein(a) apheresis

Journal of Clinical Apheresis, 2015, Vol.30 (3), p.193-195

2015

Volltextzugriff (PDF)

Immunosorbent for Selective Removal of Lipoprotein (a) from Human Plasma: In Vitro Study

Artificial organs, 1991-04, Vol.15 (2), p.136-140

1991

Volltextzugriff (PDF)

Development of Immunosorbents for apoB-Containing Lipoproteins Apheresis

Artificial organs, 1995-06, Vol.19 (6), p.500-505

1995

Volltextzugriff (PDF)

Immunosorbent for IgG apheresis: an in vitro study

Transfusion science, 1996-12, Vol.17 (4), p.519-525

1996

Volltextzugriff (PDF)

Immunosorbent for IgG apheresis: An In Vitro study

Transfusion science, 1996, Vol.17 (4), p.519-525

1996

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(30)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease

Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart Disease

Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries

The Association of Lipoprotein(a) and Circulating Monocyte Subsets with Severe Coronary Atherosclerosis

Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease

Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction

Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis

Therapeutic Apheresis for Management of Lp(a) Hyperlipoproteinemia

Lipoprotein(a) apheresis

Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia

Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting

Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography

Dramatic fate of a young coronary heart disease patient rescued with specific lipoprotein(a) apheresis

Abstract 13769: Assessing the Risk for Cardiovascular Diseases According to Lipoprotein(a) Levels

Block synthesis of blood group tetrasaccharides B (types 1, 3 and 4)

Association of lipoprotein(a) excess with early vein graft occlusions in middle-aged men undergoing coronary artery bypass surgery

Lipoprotein Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart Disease

Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis

Cascade plasma filtration during the first year after CABG in patients with hyperlipidemia refractory to statins

Extracorporeal immunoadsorption for the specific removal of lipoprotein (a) (Lp(a) apheresis): preliminary clinical data

Dramatic fate of a young coronary heart disease patient rescued with specific lipoprotein(a) apheresis

Immunosorbent for Selective Removal of Lipoprotein (a) from Human Plasma: In Vitro Study

Development of Immunosorbents for apoB-Containing Lipoproteins Apheresis

Immunosorbent for IgG apheresis: an in vitro study

Immunosorbent for IgG apheresis: An In Vitro study

Suchergebnisse filtern